203 results
8-K
EX-99.1
TEVA
Teva- Pharmaceutical Industries Ltd.
8 May 24
Teva Reports First Quarter 2024 Financial Results and Reaffirms 2024 Financial Outlook
7:01am
AUSTEDO, as well as from AJOVY in our Europe and International Markets segments, partially offset by lower revenues from COPAXONE®, and from Anda, our … of 2024, partially offset by higher gross profit, lower legal settlements and loss contingencies and lower intangible asset impairments in the first
8-K
EX-99.1
TEVA
Teva- Pharmaceutical Industries Ltd.
31 Jan 24
Results of Operations and Financial Condition
7:00am
and AJOVY, the sale of certain product rights in our Europe segment, as well as higher revenues from Anda, partially offset by lower revenues from COPAXONE … offset by higher cost of goods sold, mainly driven by higher costs due to inflationary and other macroeconomic pressures, and lower revenues from
8-K
EX-99.1
5ml2j9ro82exe82w
8 Nov 23
2023 revenues outlook revised to $15.1 - $15.5 billion from $15.0 - $15.4 billion
7:01am
8-K
EX-10.1
rhn3mn
24 Aug 23
Entry into a Material Definitive Agreement
7:30am
8-K
EX-99.1
5baft6i3e5y
2 Aug 23
Results of Operations and Financial Condition
7:00am
8-K
EX-99.1
muz6xfz06dd kizggkc
10 May 23
Results of Operations and Financial Condition
7:01am
8-K
EX-99.1
0cauu6k
3 Nov 22
Key financial highlights and outlook
7:00am
8-K
EX-99.1
v97 sa0fakhypci
26 Jul 22
Key financial highlights and outlook
4:56pm